Page 338 - Liver Diseases in Children

328 โรคตับในเด็ก

pthaigastro.org
14. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinaemia type I
by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813-7.
15. Heubi JE, Bove KE, Setchell KDR. Oral cholic acid is efficacious and well tolerated in patients with bile
acid synthesis and Zellweger spectrum disorders. J Pediatr Gastroenterol Nutr 2017;65:321-6.
16. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in
children: 37-year experience and revised King’s score for liver transplantation. Liver Transpl 2005;11:441-8.
17. Poovorawan Y, Hutagalung Y, Chongsrisawat V, Boudville I, Bock H. Dengue virus infection: a major
cause of acute hepatic failure in Thai children. Ann Trop Paediatr 2006;26:17-23.
18. Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: a curable disease by 2024? J
Hepatol 2015;62 (1 Suppl):S112-20.
19. Kulkarni S, Perez C, Pichardo C, Castillo L, Gagnon M, Beck-Sague C, et al. Use of Pediatric Health
Information System database to study the trends in the incidence, management, etiology, and outcomes
due to pediatric acute liver failure in the United States from 2008 to 2013. Pediatr Transplant 2015;19:888-95.
20. Aronson DC, Schnater JM, Staalman CR, Weverling GJ, Plaschkes J, Perilongo G, et al. Predictive
value of the pretreatment extent of disease system in hepatoblastoma: results from the International
Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005;23:1245-52.
21. Khan AS, Brecklin B, Vachharajani N, Subramanian V, Nadler M, Stoll J, et al. Liver transplantation for
malignant primary pediatric hepatic tumors. J Am Coll Surg 2017;225:103-13.
22. Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, et al. Evaluation of the pediatric patient
for liver transplantation: 2014 practice guideline by the American Association for the Study of
Liver Diseases, American Society of Transplantation and the North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition. Hepatology 2014;60:362-98.
23. Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future
perspectives. Arch Dis Child 2018;103:192-8.
24. Miloh T, Barton A, Wheeler J, Pham Y, Hewitt W, Keegan T, et al. Immunosuppression in pediatric liver
transplant recipients: unique aspects. Liver Transpl 2017;23:244-56.
25. Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM. Management and long-term
consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl 2013;19:315-21.
26. Vilca-Melendez H, Heaton N. Paediatric liver transplantation: the surgical view. Postgrad Med J 2004;80:571-6.
27. Miloh T. Medical management of children after liver transplantation. Curr Opin Organ Transplant
2014;19:474-9.
28. Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, et al. Long-term medical management
of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association
for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798-825.
29. Evans HM, Kelly DA, McKiernan PJ, Hübscher S. Progressive histological damage in liver allografts
following pediatric liver transplantation. Hepatology 2006;43:1109-17.
30. Alonso EM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, et al. Cross-sectional analysis
of health-related quality of life in pediatric liver transplant recipients. J Pediatr 2010;156:270-6.